Clean Power Hydrogen successfully demonstrates electrolyser tech

The AIM-traded firm said the achievement, witnessed by a third-party customer, underscored the scalability and effectiveness of its MFE110 system and intellectual property.

It said the MFE110 system, equipped with four 125kW stacks in a configuration identical to that of the upcoming MFE220, underwent rigorous testing and commissioning.

While the success was a crucial milestone for Clean Power Hydrogen, the company said it had also chosen to pause the MFE110 unit’s factory acceptance test (FAT) temporarily.

That decision stemmed from the accumulation of data during testing, prompting it to re-evaluate the MFE’s power-down procedures and consider necessary modifications to enhance plant shutdown processes.

Once the re-evaluation and control rectification were completed, the MFE110 unit would be transported to Northern Ireland Water’s site.

There, it would undergo site validation, integration and commissioning, paving the way for the start of commercial production of both hydrogen and medical-grade oxygen.

“Today marks a first very important step for CPH2 - we are now demonstrably capable of successfully producing separated hydrogen and oxygen gases at scale utilising the company’s differentiated technology,” said chief executive officer Jon Duffy.

“We are constantly evolving and improving our technology and look forward to finalising the factory acceptance testing of the MFE110 in collaboration with our customer, which will mark the commercialisation of our ground-breaking hydrogen technology.

“We look forward to updating shareholders in due course following the completion of the FAT testing and delivery to Northern Ireland Water.”

At 1400 GMT, shares in Clean Power Hydrogen were up 1.51% at 15.48p.

Reporting by Josh White for Sharecast.com.